Tag: nasdaq:ruby

August 7, 2018

4 Biotechnology IPOs in July

The Investing News Network provides a look back at four biotechnology stocks that launched on the NASDAQ during the month...
July 25, 2018

Rubius Therapeutics to Acquire Manufacturing Facility in Smithfield, Rhode Island to Produce Red Cell Therapeutics

Rubius Therapeutics (NASDAQ:RUBY) has announced it has signed a purchase agreement to acquire a 135,000 square foot manufacturing facility in...
July 23, 2018

Rubius Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Rubius Therapeutics (NASDAQ:RUBY) has announced the closing of its initial public offering of 12 million shares of its common stock...